ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

NIH To Replace RAC With New Committee

July 19, 1996

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995